Cite
HARVARD Citation
Brandt, E. et al. (n.d.). The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients. Journal of cardiovascular pharmacology and therapeutics. pp. 54-61. [Online].